H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 259 000 KRW -2.26%
Market Cap: 2.8T KRW
Have any thoughts about
Hugel Inc?
Write Note

Gross Margin
Hugel Inc

76.5%
Current
76%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
76.5%
=
Gross Profit
278.5B
/
Revenue
363.8B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
KR
Hugel Inc
KOSDAQ:145020
2.8T KRW
77%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
US
Abbvie Inc
NYSE:ABBV
320.1B USD
67%
US
Amgen Inc
NASDAQ:AMGN
147.4B USD
60%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
86%
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD
78%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
AU
CSL Ltd
ASX:CSL
135.4B AUD
52%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
87%
US
Seagen Inc
F:SGT
39.3B EUR
75%
NL
argenx SE
XBRU:ARGX
34.3B EUR
89%
Country KR
Market Cap 2.8T KRW
Gross Margin
77%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 320.1B USD
Gross Margin
67%
Country US
Market Cap 147.4B USD
Gross Margin
60%
Country US
Market Cap 119.4B USD
Gross Margin
86%
Country US
Market Cap 113.8B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 135.4B AUD
Gross Margin
52%
Country US
Market Cap 82.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.3B EUR
Gross Margin
89%
No Stocks Found

Hugel Inc
Glance View

Market Cap
2.8T KRW
Industry
Biotechnology

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2015-12-24. The firm's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The firm sells its products in domestic and overseas markets.

Intrinsic Value
254 607.41 KRW
Overvaluation 2%
Intrinsic Value
Price
H

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
76.5%
=
Gross Profit
278.5B
/
Revenue
363.8B
What is the Gross Margin of Hugel Inc?

Based on Hugel Inc's most recent financial statements, the company has Gross Margin of 76.5%.